Article Type

1 - 15 of 107 Results       Clear All

SF Team Seeks COVID-19 Therapies and Ways to Defeat Future Coronaviruses

Gladstone in the News March 4, 2021

SF Team Seeks COVID-19 Therapies and Ways to Defeat Future Coronaviruses

San Francisco Public Press—Senior Investigator Warner Greene describes the efforts of Gladstone scientists to discover ways to treat the acute and long-term consequences of COVID-19, and their hope of discovering antiviral approaches that could be ready for use to battle future pandemic viruses.

Gladstone Experts COVID-19 Virology Greene Lab

Coronavirus Variants Will Prolong the Pandemic. But Here’s How It Could End

Gladstone in the News January 24, 2021

Coronavirus Variants Will Prolong the Pandemic. But Here’s How It Could End

San Francisco Chronicle—The United States is trying accelerate coronavirus vaccine distribution, which could allow the country to achieve herd immunity. However, Gladstone virologist Warner Greene points out that the coronavirus is a global problem, and ending the pandemic will require mobilizing vaccines around the world.

Gladstone Experts COVID-19 Virology Greene Lab

Fetal Tissue Research, Donald Trump, and the Science behind the Politics

Gladstone in the News October 18, 2020

Fetal Tissue Research, Donald Trump, and the Science behind the Politics

San Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.

Gladstone Experts COVID-19 Virology Greene Lab

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

Gladstone in the News October 8, 2020

Trump’s Covid Treatments Were Tested in Cells Derived From Fetal Tissue

The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.

Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava Lab

What We Know about Trump’s Extraordinary COVID-19 Treatment

Gladstone in the News October 5, 2020

What We Know about Trump’s Extraordinary COVID-19 Treatment

San Francisco Chronicle—After the president was diagnosed with COVID-19, he received aggressive medical treatment. Gladstone Senior Investigator Warner Greene noted that the combination of drugs the president received has not been tested or proven effective, and that the dexamethasone he was given is a sign his illness might be more severe than it appears.

Gladstone Experts COVID-19 Virology Greene Lab

“Berlin Patient” Dies at 54: Timothy Ray Brown, the First Man Cured of HIV, Succumbs to Leukemia

Gladstone in the News September 30, 2020

“Berlin Patient” Dies at 54: Timothy Ray Brown, the First Man Cured of HIV, Succumbs to Leukemia

San Francisco Chronicle—Warner Greene, MD, PhD, director of the Center for HIV Cure Research, explains how Timothy Ray Brown, who was cured of HIV/AIDS via a bone marrow transplant, changed the field of HIV research.

Gladstone Experts HIV/AIDS Center for HIV Cure Research Greene Lab

"Exciting" Study Explains Why Men Are More Vulnerable to Coronavirus

Gladstone in the News August 27, 2020

"Exciting" Study Explains Why Men Are More Vulnerable to Coronavirus

Inverse—A new study from researchers at Yale University showed that males have a less robust T cell response to the coronavirus than females do. Gladstone virologist Warner Greene comments that this finding may in part explain why men are more likely to die from COVID-19 than women, and that it suggests men and women may benefit from different treatments.

Gladstone Experts COVID-19 Virology Greene Lab

Is Convalescent Plasma a COVID Breakthrough? Stanford Study Could Give Fresh Insights.

Gladstone in the News August 24, 2020

Is Convalescent Plasma a COVID Breakthrough? Stanford Study Could Give Fresh Insights.

San Francisco Business Times—Senior Investigator Warner Greene, MD, PhD, bemoans the disagreements among federal health leaders and the lack of coordinated federal response to the pandemic, while also expressing cautious confidence in the therapeutic value of convalescent plasma and of other immune-based therapies.

Gladstone Experts COVID-19 Greene Lab

How Will the Bay Area Distribute a Possible Coronavirus Vaccine?

Gladstone in the News August 16, 2020

How Will the Bay Area Distribute a Possible Coronavirus Vaccine?

San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, and a number of Bay Area experts explain the complexities of manufacturing and delivering vaccines against the coronavirus efficiently and safely, and stress the necessity for the scientific and health authorities to build public trust about these vaccines.

Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab

Are You a Journalist Looking to Write about Gladstone?

Explore Info for Media